Presents

Breaking News for Gene Patents: Expert Panel on Association for Molecular Pathology v. US

Wednesday, April 7th, 5:00 - 6:15 p.m.
Room 290, Stanford Law School – Food will be served

The recent decision on Association for Molecular Pathology v. US by the United States District Court, Southern District of New York, declared Myriad's BRCA gene patents invalid. This striking decision is in contrast to practice in the United States for the past 30-odd years, which has maintained that genes and associated products and methods are patentable. This panel of experts, including Stanford Law School professor and patent expert Mark Lemley, Dewey & LeBoeuf patent litigator (and former federal district court judge) Barbara Caulfield who filed an amicus brief supporting the plaintiffs, and Weil Gotshal patent litigator Ed Reines who is teaching as an adjunct at SLS. Professor Hank Greely from the Center for Law and the Biosciences will moderate.